CT News and Research

RSS

Glioblastoma tumor cells mimic neurons to evade treatment

Certain cancers are more difficult to treat because they contain cells that are highly skilled at evading drugs or our immune systems by disguising themselves as healthy cells.

11 Jan 2024

Phylogenomic analysis to generate early warning signs for COVID-19 waves

The Transmission Fitness Polymorphism (TFP) scanner analysis pipeline to detect severe acute respiratory syndrome coronavirus 2.

11 Jan 2024

Cardiovascular disease deaths tied to substance use jump 4% per year from 1999 to 2019

Cardiovascular disease deaths involving substance use rose an average of 4% per year from 1999 to 2019, despite a drop in overall cardiovascular disease deaths, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

10 Jan 2024

Scooter injuries nearly tripled across the U.S. from 2016 to 2020, leading to increased hospitalizations

UCLA-led research finds that scooter injuries nearly tripled across the U.S. from 2016 to 2020, with a concurrent increase in severe injuries requiring orthopedic and plastic surgery over the same period.

9 Jan 2024

Closing the gap: PATROL's approach to overcoming lung cancer diagnostic inequality

A non-invasive, low-cost lung cancer detection platform called PATROL.

9 Jan 2024

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S..

From QIAGEN Manchester Limited 9 Jan 2024

Marking a vital milestone for Vertex and Charles River

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

From Charles River 9 Jan 2024

New study reveals widespread diagnostic errors in seriously ill hospitalized adults

A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.

8 Jan 2024

Inhalable point-of-care urinary diagnostic platform for early lung cancer detection

Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.

5 Jan 2024

Unmasking the persistent threats of long-COVID's pulmonary sequelae

A collaborative study led by Dr. Estefanía Nova-Lamperti of the Universidad de Concepción, Dr. Gonzalo Labarca of Harvard University, and Mauricio Hernández, of MELISA Institute, and which included the participation of researchers from leading academic institutions, sought to identify the sequelae associated with long-term pulmonary dysfunction (L-PDD) in patients with COVID-19.

4 Jan 2024

Eastern equine encephalitis virus study uncovers decoy molecule that protects against deadly brain infection

An atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells also has enabled the discovery of a decoy molecule that protects against the potentially deadly brain infection, in mice.

3 Jan 2024

AI-generated images promise to transform medical diagnostics

Diagnosing cancer today involves using chemical "contrast agents" to improve the accuracy of medical imaging processes such as X-rays as well as computed tomography (CT) and magnetic resonance imaging (MRI) scans.

3 Jan 2024

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

PET imaging with 68Ga-FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in the December issue of The Journal of Nuclear Medicine.

2 Jan 2024

Novel PET tracer accurately detects common cancer mutation for tailored treatment

A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy.

2 Jan 2024

Endocrine Society applauds Ohio Governor DeWine's veto of anti-transgender healthcare bill

The Endocrine Society, the world's oldest and largest professional medical society devoted to the study and treatment of hormone-related conditions, applauds Governor Mike Dewine's veto of a proposed Ohio law that would have banned gender-affirming care for minors.

29 Dec 2023

IASLC publishes key considerations for managing low-dose CT lung cancer screening programs

Annual low-dose CT screening has been recently shown to result in high cure rates of over 80%, but methods of conducting a lung cancer screening program vary and best practices have yet to emerge.

20 Dec 2023

Study demonstrates benefits of lung nodule program in expanding access to early diagnosis

Adopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not eligible for lung cancer screening under existing age eligibility criteria, according to a study published in the Journal of Thoracic Oncology, an official journal of the International Association for the Study of Lung Cancer.

18 Dec 2023

Hospitalized influenza patients can also suffer long-term, negative health effects

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus's ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling health problems known as long COVID.

14 Dec 2023

Infective endocarditis deaths spike among young adults, research shows

Death rates related to infective endocarditis declined in most adults across the U.S. within the last two decades, yet accelerated among young adults ages 25 to 44 years old, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

13 Dec 2023

Smartwatches help physicians to diagnose arrhythmias in children

Smartwatches can help physicians detect and diagnose irregular heart rhythms in children, according to a new study from the Stanford School of Medicine.